2025 Volume 51 - Canada Communicable Disease Report (CCDR)

ISSN: 1481-8531

2025 Volume 51

CCDR Volume 51-4, April 2025: Challenges in Managing Gonorrhea and Prevention

• Summary of the National Advisory Committee on Immunization (NACI) Statement on the Prevention of Respiratory Syncytial Virus (RSV) in Infants
• Environmental scan of available guidelines for chlamydia and gonorrhea screening recommendations for non-pregnant adolescents/adults in developed countries
• Antimicrobial susceptibilities of Neisseria gonorrhoeae in Canada, 2022
• A rapid review of the avian influenza PB2 E627K mutation in human infection studies
• Associations between self-reported SARS-CoV-2 infection status, serology and common longer-term COVID-19 symptoms among adults in Canada, a cross-sectional study
• Screening of retail milk in Ontario for the presence of influenza A viral RNA
• Tips for Safely Handling Backyard Flock Eggs

CCDR Volume 51-2/3, February/March 2025: Health Economics in Public Health

• Cost-effectiveness of respiratory syncytial virus vaccination strategies for older Canadian adults: A multi-model comparison
• Comparison of 13-, 15- and 20-valent pneumococcal conjugate vaccines in the paediatric Canadian population: a cost-utility analysis
• Cost effectiveness of a 21-valent pneumococcal conjugate vaccine in adults: A systematic review of economic evaluations
• Public Health Risks Associated with Dog Importation
• Summary of the mpox outbreak in Canada, April 28−December 31, 2022
• Differences in sensationalism in international news media reporting of COVID-19: An exploratory analysis using the Global Public Health Intelligence Network (GPHIN) system
• Infectious syphilis and congenital syphilis in Canada, 2023

CCDR Volume 51-1, January 2025: Personal Protective Measures

• Summary of the National Advisory Committee on Immunization (NACI) Statement—Updated guidance on Imvamune in the context of a routine immunization program
• Is there sufficient evidence to inform personal protective equipment choices for healthcare workers caring for patients with viral hemorrhagic fevers?
• Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2023
• Burden of disease of respiratory syncytial virus in older adults and adults considered at high risk of severe infection
• The prevalence of HIV pre-exposure prophylaxis (HIV-PrEP) use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018–2021
• Using behavioural science to improve antibiotic stewardship in Canadian long-term care homes: Protocol for a multi-center cluster randomized quality improvement study